Demand for Virology in Japan

Future Market Insights

Key Insight

The demand for virology in Japan is projected to grow from USD 121.3 million in 2025 to USD 175.3 million by 2035, at a CAGR of 3.8%. Diagnostic Tests will dominate with a 46.0% market share, while skin and soft tissue infections will lead the application segment with a 20.0% share.

December 15, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Virology in Japan

https://www.futuremarketinsights.com/reports/japan-virology-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Takeda Pharmaceuticals
Tevogen Bio
VerImmune Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Virology in Japan

Key Players

Similar Industry Reports